Status | Study |
Completed |
Study Name: Therapy of Chronic Cold Agglutinin Disease With Eculizumab Condition: Cold Agglutinin Disease Date: 2011-02-24 Interventions: Drug: Eculizumab Weekly treatment with eculizumab (600 mg) via IV infusion for 4 doses followed the next |
Active, not recruiting |
Study Name: Rituximab in Auto-Immune Hemolytic Anemia Condition: Warm Autoimmune Hemolytic Anemia Date: 2010-08-12 Interventions: Drug: rituximab (Mabthera®) |
Completed |
Study Name: Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia Condition: Anemia, Hemolytic, Autoimmune Date: 2010-05-28 Interventions: Drug: prednisolone + mabthera |
Completed |
Study Name: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders Condition: Pemphigus Auto-immune Thrombocytopenic Purpura Date: 2009-07-16 Interventions: Drug: Rituximab (MABTHERA® or RITUXAN®). patients can be included in the study whatever the do |
Completed |
Study Name: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias Condition: Idiopathic Thrombocytopenic Purpura Anemia, Hemolytic, Autoimmune Date: 2008-09-08 Interventions: Drug: Alemtuzumab, Rituximab Alemtuzumab 10 mg each 24 hrs subcutaneous for 3 days. Rituximab 100 mg IV |
Active, not recruiting |
Study Name: Sirolimus for Autoimmune Disease of Blood Cells Condition: Autoimmune Pancytopenia Autoimmune Lymphoproliferative Syndrome (ALPS) Date: 2006-10-24 Interventions: Drug: sirolimus Tablet or liquid; taken once or twice daily; dosage is based on establishing a serum tro |
Completed |
Study Name: Therapy for Chronic Cold Agglutinin Disease Condition: Cold Agglutinin Disease Date: 2006-09-07 Interventions: Drug: Rituximab Drug: Fludarabine |
Completed |
Study Name: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) Condition: Chronic Lymphocytic Leukemia Date: 2006-03-29 Interventions: Biological: rituximab Drug: cyclophosphami |
Completed |
Study Name: Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease Condition: Anemia, Hemolytic, Autoimmune Felty Syndrome Date: 2001-02-02 Interventions: Drug: cyclophosphamide Drug: filgrastim |
Completed |
Study Name: Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Condition: Purpura, Schoenlein-Henoch Graft Versus Host Disease Date: 2000-07-05 Interventions: Drug: anti-thymocyte globulin Drug: cyclop |